FDA Approves Cabtreo (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris

LAVAL, Quebec, Oct. 20, 2023– Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and its dermatology business, Ortho Dermatologics, today announced that the U.S. Food and Drug Administration (FDA) has approved the New...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news